42
DAFTAR PUSTAKA
1. Trihono PP, Alatas H, Tambunan T, Pardede S. Konsensus tatalaksana sindroma nefrotik idiopatik pada anak. Jakarta : Badan Penerbit Ikatan Dokter Anak Indonesia; 2012.h.1-22
2. Pais P, Avner ED. Nephrotic syndrome. In: Kliegman RM, Stanton BF, Schor NF, Geme JW, Behrman RE, editors. Nelson textbook of pediatrics. 19th ed. United States: Elsevier, 2011. p.1801-7
3. Gulleroglu K, Yazar B, Sakalli H, Ozdemir H, Baskin E. Clinical importance of mean platelet volume in children with nephrotic syndrome. Ren Fail. 2014; 36(5):663–5
4. Eneman B, Levtchenko E, Heuvel BV, Geet CV, Freson K. Platelet abnormalities in nephrotic syndrome. Pediatr Nephrol. 2015; 1-13 5. Kerlin BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, et al.
Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a midwest pediatric nephrology consortium (mwpnc) study. J Pediatr. 2009; 155(1):1-14
6. Noer MS. Sindroma nefrotik idiopatik. Dalam : Soemyarso NA, Subandiyah K, Prasetyo RV, Alatas H, Tambunan T, MS Noer ,dkk, penyunting. Kompendium Nefrologi Anak. Jakarta : Badan Penerbit Ikatan Dokter Anak Indonesia; 2011. h. 72-88
7. Wila Wirya IGN. Penelitian beberapa aspek klinis dan patologi anatomis sindrom nefrotik primer pada anak di Jakarta.(disertasi). Medan: Universitas Indonesia, 1992.
8. Hafni A, Hilmanto D, Rachmadi D, Sekarwana N. Trombocytosis in childhood relapsing nephrotic syndrome. Sari Pediatri. 2007; 47(3):100-3
9. Wasilewska AM, ZochZwierz WM, Tomaszewska B, Biernacka A. Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome. Pediatr Nephrol. 2005; 20:36–41
10. Cure MC, Cure E, Yuce S, Yazici T, Karakoyun I, Efe H. Mean platelet volume and vitamin d level. Ann Lab Med. 2014; 34:98-103
11. Lippi G, Franchini M. Platelets and immunity: the interplay of mean platelet volume in health and disease. Expert Rev Hematol. 2015:1–3 12. Kocyigit I, Yilmaz MI, Simsek Y, Unal A, Sipahioglu MH, Eroglu E, et
al. The role of platelet activation in determining response to therapy in patients with primary nephrotic syndrome. Platelets. 2013; 24(6):474-9 13. Akbal A, Gokmen F, Gencer M, Inceer BS, Kumurcu E. Mean platelet volume and platelet distribution width can be related to bone mineralization. Osteoporos Int. 2014; 1-5
14. Jackson SR, Carter JM. Platelet volume: laboratory measuremwnt and clinical application. Blood Rev. 1993; 7:104-13
43
18. Grimbert P, Audard V, Remy P, Lang P, Sahali D. Recent approaches to the pathogenesis of minimal-change nephrotic syndrome. Nephrol Dial Transplant. 2003; 18: 245-8
19. Subramaniam N, Mundkur S, Kini P, Bhaskaranand N, Aroor S. Clinicohematological study of thrombocytosis in children. ISRN Hematol. 2014; 1-4
20. Ueda N. Effect of corticosteroids on some hemostatic parameters in children with minimal change nephrotic syndrome. Nephron. 1990; 56:374-8
21. Choi JL, Li S, Han JY. Platelet function tests: a review of progresses in clinical application. Biomed Res Int. 2014; 1-7
22. Hoffbrand AV, Pettit JE, Moss PAH. Essential haematology. 4th ed. Oxford: Blackwell Science; 2001. p.286-7.
23. Wirawan R. Nilai rujukan pemeriksaan agregasi trombosit dengan adenosis difosfat pada orang indonesia dewasa normal di jakarta. Maj Kedokt Indon. 2007; 57(7): 212-9
24. Lubis B, Rosdiana N. Trombositosis. Dalam: Permono HB, Sutaryo, Ugrasena IDG, Windiastuti E, Abdulsalam M, penyunting. Buku ajar hematologi-onkologi anak. Edisi ketiga. Jakarta: Ikatan Dokter Anak Indonesia, 2010. h.169-73
25. Gunawan S, Sutanto FC, Tatura SN, Mantik MF. Platelet distribution width dan mean platelet volume: hubungan dengan derajat penyakit demam berdarah dengue. Sari Pediatri. 2010; 12(2):74-7
26. Colkesen Y, Muderrisoglu H. The role of mean platelet volume in predicting thrombotic events. Clin Chem Lab Med. 2012; 50(4):631–44 27. Wilar R, Antolis Y, Tatura SN, Gunawan S. Jumlah trombosit dan
mean platelet volume sebagai faktor prognosis pada sepsis neonatorum. Sari Pediatri. 2010; 12(1):53-7
28. Zheng YG, Yang T, Xiong CM, He JG, Liu ZH, Gu Q, et al. Platelet distribution width and mean platelet volume in idiopathic pulmonary arterial hypertension. Heart Lung Circ. 2015; 24:566-74
29. Shah AR, Chaudhari SN, Shah MH. Role of platelet parameters in diagnosing various clinical conditions. Natl J Med Res. 2013; 3(2):162-5
44 30. Oncel E, Ozsurekci Y, Kara A, Karahan S, Cengiz AB, Ceyhan M. The value of mean platelet volume in the determination of community acquired pneumonia in children. Ital J Pediatr. 2013; 39(16):1-5
31. Safak S, Uslu AU, Serdal K, Turker T, Soner S, Lutfi A. Association between mean platelet volume levels and inflammation in SLE patients presented with arthritis. Afr Health Sci. 2014; 14(4):919-24 32. Park Y, Schoeneb N, Harris W. Mean platelet volume as an indicator
of platelet activation: methodological issues. Platelets. 2002; 13:301-6 33. Pervin S, Ferdousy S, Hossain M, Joarder A, Sultana T. Elevated
mean platelet volume is a marker of acute coronary syndrome. Bangladesh Med J. 2013; 42(2):45-50
34. Han JS, Park TS, Cho SY, Joh JH, Ahn HJ. Increased mean platelet volume and mean platelet volume/platelet count ratio in Korean patients with deep vein thrombosis. Platelets. 2013; 24(8): 590–3 35. Shimodaira M, Niwa T, Nakajima K, Kobayashi M, Hanyu N,
Nakayama T. Correlation between mean platelet volume and blood glucose levels after oral glucose loading in normoglycemic and prediabetic Japanese subjects. J Diabetes Invest.2014; 5: 66–71 36. Kalkan A, Memetoglu ME. Is increased mean platelet volume a risk
factor in patients with acute deep vein thrombosis?. Tr J Emerg Med. 2012; 12(2):82-6
37. Gurler M, Aktas G. A review of the association of mean platelet volume and red cell distribution width in inflammation. Int J Res Med Sci. 2016; 4(1):1-4
38. Balbaloglu O, Korkmaz M, Yolcu S, Karaaslan F. Evaluation of mean platelet volume (MPV) levels in patients with synovitis associated with knee osteoarthritis. Platelets. 2013; 1–5
39. Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome associated thromboembolic disease. Clin J Am Soe Nephrol. 2012; 7:513-20
40. Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: Pathophysiology and clinical management. Thromb Res. 2006; 118:397—407
41. Rani AS. A study of PT, APTT, fibrinogen and urinary protein-creatinine ratio in paediatric patien. ts with nephrotic syndrome. Int J Contemp Pediatr. 2014; 1(2):89-93
42. Noer MS. Predictors of relapse in steroid-sensitive nephrotic syndrome. Southeast Asian J Trop Med Public Health. 2005; 36(5): 1313-20
43. Alhassan A, Mohamed WZ, Alhaymed M. Patterns of childhood nephrotic syndrome in aljouf region, saudi arabia. Saudi J Kidney Dis Transpl.2013; 24(5):1050-4
45 44. Cil H, Yavuz C, Islamog Y, Tekbas EO, Demirtas S, Atilgan ZA, et al. Platelet count and mean platelet volume in patients with in-hospital deep venous thrombosis. Clin Appl Thromb/Haemost. 2012; 18(6):650-3
45. Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia. 2010; 14(1):28-32